Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
CVS Health plans to expand its retail footprint this year after contracting it over the past four years, Bloomberg reported Monday (March 30). The retail pharmacy chain plans to open 60 stores this year, including 20 small pharmacy-only sites, while closing “a few dozen locations,” the report said, citing CVS spokesperson Amy Thibault.
Proposed flat reimbursement rates for Medicare Advantage pressure recovery prospects, with CVS likely to suffer enrollment declines from the higher premiums through FY2027. Despite so, their diversified healthcare segments are likely to support their sustainable operations, aided by the potentially healthier membership base at higher rates. Thanks to the industry-wide pessimism, CVS is now undervalued at FWD P/E of 9.97x and 3Y PEG of 0.85x, with it triggering a bull-case PT of $83.60.
CVS Health (CVS) concluded the recent trading session at $72.8, signifying a +2.12% move from its prior day's close.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
In the most recent trading session, CVS Health (CVS) closed at $74.81, indicating a -1.36% shift from the previous trading day.
California Public Employees Retirement System increased its stake in CVS Health Corporation (NYSE: CVS) by 5.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,333,350 shares of the pharmacy operator's stock after purchasing an additional 123,846 shares during the
Ameriprise Financial Inc. grew its holdings in shares of CVS Health Corporation (NYSE: CVS) by 7.5% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 8,448,420 shares of the pharmacy operator's stock after buying an additional 592,575 shares during the period. Ameriprise Financial Inc.
8 Knots Management LLC purchased a new stake in CVS Health Corporation (NYSE: CVS) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 1,174,797 shares of the pharmacy operator's stock, valued at approximately $88,568,000. CVS Health makes up approximately 10.0% of 8 Knots
Callodine Capital Management LP lowered its stake in CVS Health Corporation (NYSE: CVS) by 39.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 313,427 shares of the pharmacy operator's stock after selling 204,573 shares during the period. CVS Health
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?